BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21120947)

  • 1. High-Resolution genomic arrays identify CNVs that phenocopy the chromosome 22q11.2 deletion syndrome.
    Busse T; Graham JM; Feldman G; Perin J; Catherwood A; Knowlton R; Rappaport EF; Emanuel B; Driscoll DA; Saitta SC
    Hum Mutat; 2011 Jan; 32(1):91-7. PubMed ID: 21120947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays.
    Beaujard MP; Chantot S; Dubois M; Keren B; Carpentier W; Mabboux P; Whalen S; Vodovar M; Siffroi JP; Portnoï MF
    Eur J Med Genet; 2009; 52(5):321-7. PubMed ID: 19467348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical presentations of 22q11.2 deletion syndrome: explaining the genetic defects and genome architecture.
    Tuţulan-Cuniţă AC; Budişteanu M; Papuc SM; Dupont JM; Blancho D; Lebbar A; Viot G; Lungeanu A; Arghir A
    Psychiatry Res; 2012 May; 197(3):356-7. PubMed ID: 22365273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
    Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
    Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
    McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
    Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
    Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
    Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DiGeorge syndrome: new insights.
    Goldmuntz E
    Clin Perinatol; 2005 Dec; 32(4):963-78, ix-x. PubMed ID: 16325672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 22q11.2 deletion syndrome.
    Emanuel BS; McDonald-McGinn D; Saitta SC; Zackai EH
    Adv Pediatr; 2001; 48():39-73. PubMed ID: 11480765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Philadelphia story: the 22q11.2 deletion: report on 250 patients.
    McDonald-McGinn DM; Kirschner R; Goldmuntz E; Sullivan K; Eicher P; Gerdes M; Moss E; Solot C; Wang P; Jacobs I; Handler S; Knightly C; Heher K; Wilson M; Ming JE; Grace K; Driscoll D; Pasquariello P; Randall P; Larossa D; Emanuel BS; Zackai EH
    Genet Couns; 1999; 10(1):11-24. PubMed ID: 10191425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural tube defects and deletions of 22q11.
    Nickel RE; Magenis RE
    Am J Med Genet; 1996 Dec; 66(1):25-7. PubMed ID: 8957506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurrence of recurrent duplications of the DiGeorge syndrome region on both chromosome 22 homologues due to inherited and de novo events.
    Bi W; Probst FJ; Wiszniewska J; Plunkett K; Roney EK; Carter BS; Williams MD; Stankiewicz P; Patel A; Stevens CA; Lupski JR; Cheung SW
    J Med Genet; 2012 Nov; 49(11):681-8. PubMed ID: 23042811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH.
    Bittel DC; Yu S; Newkirk H; Kibiryeva N; Holt A; Butler MG; Cooley LD
    Cytogenet Genome Res; 2009; 124(2):113-20. PubMed ID: 19420922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakpoint Associated with a novel 2.3 Mb deletion in the VCFS region of 22q11 and the role of Alu (SINE) in recurring microdeletions.
    Uddin RK; Zhang Y; Siu VM; Fan YS; O'Reilly RL; Rao J; Singh SM
    BMC Med Genet; 2006 Mar; 7():18. PubMed ID: 16512914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genotype and phenotype study of two patients with 22q11.2 deletion syndrome].
    Zhu H; Wang A; Zhang H; Ji C; Zhan X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Oct; 31(5):623-7. PubMed ID: 25297596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital heart defects and chromosomal anomalies including 22q11 microdeletion (CATCH 22).
    Soares G; Alvares S; Rocha C; Teixeira MF; Mota MC; Reis MI; Feijó MJ; Lima MR; Pinto MR
    Rev Port Cardiol; 2005 Mar; 24(3):349-71. PubMed ID: 15929620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 22q11 deletions in patients with selected outflow tract malformations.
    Frohn-Mulder IM; Wesby Swaay E; Bouwhuis C; Van Hemel JO; Gerritsma E; Niermeyer MF; Hess J
    Genet Couns; 1999; 10(1):35-41. PubMed ID: 10191427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
    Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
    In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.